SPIA
AEON icon

Steward Partners Investment Advisory’s AEON Biopharma AEON Stock Holding History

Steward Partners Investment Advisory’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08K Buy
1,100
+1,000
+1,000% +$1.12K ﹤0.01% 4174
2025
Q4 		$110 Hold
100
– – ﹤0.01% 4221
2025
Q3 		$81 Hold
100
– – ﹤0.01% 4197
2025
Q2 		$76 Hold
100
– – ﹤0.01% 4049
2025
Q1 		$58 Sell
100
-14
-12% -$100 ﹤0.01% 3957
2024
Q4 		$4.43K Buy
114
+14
+14% +$815 ﹤0.01% 3399
2024
Q3 		$7.56K Buy
+100
New +$8.8K ﹤0.01% 3056

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Steward Partners Investment Advisory's AEON Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its AEON Biopharma (AEON) stake by 1,000% in Q1 2026, buying an estimated $1.12K and bringing the position to 1,100 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #4174.

Steward Partners Investment Advisory first reported a position in AEON in Q3 2024 and has held it in 7 quarters since. The position peaked at $7.56K in Q3 2024. 24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

  • Steward Partners Investment Advisory held 1,100 shares of AEON Biopharma worth $1.08K as of Q1 2026.
  • Steward Partners Investment Advisory bought 1,000 AEON Biopharma shares in Q1 2026, an estimated $1.12K.
  • AEON Biopharma made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4174 holding.
  • Steward Partners Investment Advisory first reported a position in AEON Biopharma in Q3 2024 and has held it in 7 quarters since.
  • Steward Partners Investment Advisory's AEON Biopharma position peaked at $7.56K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.